Amid buzz around a short seller’s FBI visit, MiMedx stock craters following internal investigation
A biopharma in Georgia tied to an unusual FBI story is watching its stock tumble this morning following news that the company is launching an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
